Clinical Utility of Endoscopic Submucosal Dissection

Condition: Gastrointestinal mucosal/submucosal disease

Eligibility

Key Inclusion Criteria

  • At least 18 years old
  • Scheduled to undergo ESD as part of standard-of-care treatment

Key Exclusion Criteria

  • Any contraindication to performing endoscopy
  • Participation in another research study that could interfere with or influence the outcome of this study

Full Study Name

Multicenter Prospective Evaluation of the Clinical Utility of Endoscopic Submucosal Dissection (ESD) in the Western Population (IRB no. 49132)

Summary

This study focuses on individuals who have a mass or nodule anywhere in the esophagus, stomach or intestines and who have been scheduled for an endoscopic submucosal dissection (ESD) procedure. The purpose of the study is to collect clinical information about individuals who undergo ESD at Cedars-Sinai. ESD is an advanced endoscopic procedure used to treat abnormalities on the wall of the gastrointestinal tract (esophagus, stomach or intestine).

By using ESD, the need for open surgery is avoided, and large areas of affected tissue can be removed in one piece while protecting the healthy areas. Researchers believe it is important to obtain information on how patients respond to ESD treatment so that it can be used in large patient populations who need endoscopic treatment for gastrointestinal abnormalities.

Principal Investigator

Laith Jamil, MD

Contact
Liliana (Claudia) Bancila, PhD
Phone: 310-423-3872
Email: liliana.bancila@cshs.org